ENTRY       D11236                      Drug
NAME        Lenzilumab (USAN/INN)
FORMULA     C6474H10024N1748O2010S42
EXACT_MASS  145760.4168
MOL_WEIGHT  145850.098
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYSFT NYYIHWVRQA PGQRLEWMGW INAGNGNTKY
            SQKFQGRVTI TRDTSASTAY MELSSLRSED TAVYYCVRRQ RFPYYFDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            EIVLTQSPAT LSVSPGERAT LSCRASQSVG TNVAWYQQKP GQAPRVLIYS TSSRATGITD
            RFSGSGSGTD FTLTISRLEP EDFAVYYCQQ FNKSPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-GM-CSF antibody
  TYPE      Monoclonal antibody
TARGET      CSF2 [HSA:1437] [KO:K05427]
  PATHWAY   hsa04060(1437)  Cytokine-cytokine receptor interaction
            hsa04640(1437)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               CSF and other factors
                CSF2
                 D11236  Lenzilumab (USAN/INN)
DBLINKS     CAS: 1229575-09-0
            PubChem: 384585214
///
